Merck acquisition of OncoImmune: A strategic move to strengthen COVID-19 treatment pipeline
In a significant acquisition aimed at enhancing its COVID-19 therapeutic offerings, pharmaceutical giant Merck has entered into an all-cash deal valued at $425 million to ... Read More